Two Sigma Advisers LP Cuts Stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Two Sigma Advisers LP lessened its stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 369,476 shares of the company’s stock after selling 56,100 shares during the period. Two Sigma Advisers LP owned about 1.00% of Crescent Capital BDC worth $7,101,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in CCAP. Franklin Resources Inc. increased its stake in shares of Crescent Capital BDC by 12.8% during the 4th quarter. Franklin Resources Inc. now owns 289,131 shares of the company’s stock worth $5,557,000 after purchasing an additional 32,852 shares during the last quarter. Condor Capital Management grew its holdings in Crescent Capital BDC by 4.7% during the fourth quarter. Condor Capital Management now owns 284,055 shares of the company’s stock valued at $5,460,000 after purchasing an additional 12,852 shares during the period. Wells Fargo & Company MN increased its position in Crescent Capital BDC by 0.5% in the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company’s stock worth $4,866,000 after buying an additional 1,210 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Crescent Capital BDC in the fourth quarter worth $3,750,000. Finally, Denali Advisors LLC raised its stake in shares of Crescent Capital BDC by 0.5% in the fourth quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock valued at $3,532,000 after buying an additional 855 shares during the period. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Trading Up 0.4%

Shares of Crescent Capital BDC stock opened at $15.39 on Friday. The company’s 50-day moving average price is $16.02 and its 200-day moving average price is $17.99. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. Crescent Capital BDC, Inc. has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a market cap of $570.35 million, a price-to-earnings ratio of 7.73 and a beta of 0.63.

Crescent Capital BDC (NASDAQ:CCAP) last posted its earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The firm had revenue of $42.13 million during the quarter, compared to analysts’ expectations of $45.08 million. On average, equities analysts expect that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Monday, June 30th will be paid a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 10.92%. The ex-dividend date of this dividend is Monday, June 30th. Crescent Capital BDC’s dividend payout ratio is 125.37%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CCAP shares. Wall Street Zen downgraded Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Thursday. Raymond James dropped their price objective on shares of Crescent Capital BDC from $20.00 to $17.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Keefe, Bruyette & Woods downgraded shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and reduced their target price for the stock from $18.50 to $17.00 in a research note on Friday, May 16th. Finally, Wells Fargo & Company lowered their price target on shares of Crescent Capital BDC from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Friday, May 16th. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $17.60.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.